OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review
OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
OraSure Technologies Inc (OraSure) develops, manufactures and distributes oral fluid diagnostic and collection devices and other diagnostic products for detection and diagnosis of critical medical conditions. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola virus, Zika virus and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.
OraSure Technologies Inc Key Recent Developments
Mar 01,2021: OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update
Nov 04,2020: OraSure Technologies announces third quarter 2020 financial results and provides update on COVID-19 developments
Oct 21,2020: OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET
Aug 05,2020: OraSure Technologies announces 2020 second quarter financial results and update on COVID-19 testing programs
May 12,2020: OraSure Technologies consolidates Microbiome services subsidiaries
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
OraSure Technologies Inc (OraSure) develops, manufactures and distributes oral fluid diagnostic and collection devices and other diagnostic products for detection and diagnosis of critical medical conditions. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola virus, Zika virus and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.
OraSure Technologies Inc Key Recent Developments
Mar 01,2021: OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update
Nov 04,2020: OraSure Technologies announces third quarter 2020 financial results and provides update on COVID-19 developments
Oct 21,2020: OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET
Aug 05,2020: OraSure Technologies announces 2020 second quarter financial results and update on COVID-19 testing programs
May 12,2020: OraSure Technologies consolidates Microbiome services subsidiaries
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
OraSure Technologies Inc - Key Facts
OraSure Technologies Inc - Key Employees
OraSure Technologies Inc - Key Employee Biographies
OraSure Technologies Inc - Major Products and Services
OraSure Technologies Inc - History
OraSure Technologies Inc - Company Statement
OraSure Technologies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
OraSure Technologies Inc - Business Description
Business Segment: DNAG
Overview
Performance
Business Segment: OSUR
Overview
Performance
Business Segment: Other
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other Regions
Target Markets
Performance
Geographical Segment: United States
Performance
OraSure Technologies Inc - Corporate Strategy
OraSure Technologies Inc - SWOT Analysis
SWOT Analysis - Overview
OraSure Technologies Inc - Strengths
OraSure Technologies Inc - Weaknesses
OraSure Technologies Inc - Opportunities
OraSure Technologies Inc - Threats
OraSure Technologies Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OraSure Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
OraSure Technologies Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 01, 2021: OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update
Nov 04, 2020: OraSure Technologies announces third quarter 2020 financial results and provides update on COVID-19 developments
Oct 21, 2020: OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET
Aug 05, 2020: OraSure Technologies announces 2020 second quarter financial results and update on COVID-19 testing programs
May 12, 2020: OraSure Technologies consolidates Microbiome services subsidiaries
May 06, 2020: OraSure announces 2020 first quarter financial results and provides covid-19 update
May 05, 2020: OraSure Technologies appoints Lisa Nibauer as Infectious Disease Business Unit Lead
Apr 08, 2020: OraSure Technologies appoints David J. Shulkin, M.D. to board of directors
Feb 19, 2020: OraSure announces 2019 full year and fourth quarter financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
OraSure Technologies Inc - Key Facts
OraSure Technologies Inc - Key Employees
OraSure Technologies Inc - Key Employee Biographies
OraSure Technologies Inc - Major Products and Services
OraSure Technologies Inc - History
OraSure Technologies Inc - Company Statement
OraSure Technologies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
OraSure Technologies Inc - Business Description
Business Segment: DNAG
Overview
Performance
Business Segment: OSUR
Overview
Performance
Business Segment: Other
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other Regions
Target Markets
Performance
Geographical Segment: United States
Performance
OraSure Technologies Inc - Corporate Strategy
OraSure Technologies Inc - SWOT Analysis
SWOT Analysis - Overview
OraSure Technologies Inc - Strengths
OraSure Technologies Inc - Weaknesses
OraSure Technologies Inc - Opportunities
OraSure Technologies Inc - Threats
OraSure Technologies Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OraSure Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
OraSure Technologies Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 01, 2021: OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update
Nov 04, 2020: OraSure Technologies announces third quarter 2020 financial results and provides update on COVID-19 developments
Oct 21, 2020: OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET
Aug 05, 2020: OraSure Technologies announces 2020 second quarter financial results and update on COVID-19 testing programs
May 12, 2020: OraSure Technologies consolidates Microbiome services subsidiaries
May 06, 2020: OraSure announces 2020 first quarter financial results and provides covid-19 update
May 05, 2020: OraSure Technologies appoints Lisa Nibauer as Infectious Disease Business Unit Lead
Apr 08, 2020: OraSure Technologies appoints David J. Shulkin, M.D. to board of directors
Feb 19, 2020: OraSure announces 2019 full year and fourth quarter financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
OraSure Technologies Inc, Key Facts
OraSure Technologies Inc, Key Employees
OraSure Technologies Inc, Key Employee Biographies
OraSure Technologies Inc, Major Products and Services
OraSure Technologies Inc, History
OraSure Technologies Inc, Other Locations
OraSure Technologies Inc, Subsidiaries
OraSure Technologies Inc, Key Competitors
OraSure Technologies Inc, Ratios based on current share price
OraSure Technologies Inc, Annual Ratios
OraSure Technologies Inc, Annual Ratios (Cont...1)
OraSure Technologies Inc, Annual Ratios (Cont...2)
OraSure Technologies Inc, Interim Ratios
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OraSure Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
OraSure Technologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
OraSure Technologies Inc, Key Facts
OraSure Technologies Inc, Key Employees
OraSure Technologies Inc, Key Employee Biographies
OraSure Technologies Inc, Major Products and Services
OraSure Technologies Inc, History
OraSure Technologies Inc, Other Locations
OraSure Technologies Inc, Subsidiaries
OraSure Technologies Inc, Key Competitors
OraSure Technologies Inc, Ratios based on current share price
OraSure Technologies Inc, Annual Ratios
OraSure Technologies Inc, Annual Ratios (Cont...1)
OraSure Technologies Inc, Annual Ratios (Cont...2)
OraSure Technologies Inc, Interim Ratios
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OraSure Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
OraSure Technologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
OraSure Technologies Inc, Performance Chart (2016 - 2020)
OraSure Technologies Inc, Ratio Charts
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OraSure Technologies Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021
OraSure Technologies Inc, Performance Chart (2016 - 2020)
OraSure Technologies Inc, Ratio Charts
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OraSure Technologies Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021